We are monitoring the impact of COVID-19 on North America Acne Medication Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 6559
Share on
Share on

North America Acne Medication Market Research Report – Segmented By Type, Route Of Administration, Drug Class and Country (the United States, Canada and Rest of North America) - Industry Analysis, Size, Share, Growth, Trends and Forecast (2021 to 2026)

Pulished: April, 2021
ID: 6559
Pages: 145

North America Acne Medication Market Size (2021 to 2026)

The size of the North America Acne Medication Market is forecasted to hike at a promising CAGR from 2021 to 2026.

The reason for the growth in the market is the increase in the air level in the air, which causes acne on the skin. The rise in population is mainly due to the increased number of vehicles and industrialization in states. People now have unhealthy eating disorders, mainly due to a more hectic and unhealthier lifestyle, which causes acne and boosts the acne treatment market. People now have more throwaway income than previous times and are more willing to spend on acne treatment than just avoiding it. There is currently an increased presence of acne treatments growing in home remedies and effective laser treatment, driving the market growth.

There is a lot of competition for acne treatment medicines at the entry point, restraining a single product's growth, and impacting its overall development. The introduction of generic medications, which are quite useful in treatment than other medicines, have restricted their growth in the North American market. There has also been a lot of findings regarding the side effects of acne treatment medicines. As these reports are now available to the public, the people have become aware of it and cautious in using medications. Safety concerns about the medication about how severely it will affect the body have also hampered the market growth.

The North America market for Acne Medication is broadly categorized into type, route of administration, and drug class:

By Type:

  • OTC drugs
  • Prescription drugs

By Route of Administration:

  • Topical
  • Oral

By Drug Class:

  • Antibiotics
  • Anti-Inflammatory Drugs
  • Anti-Microbial
  • Combination Drugs
  • Hormonal Agents
  • Oral Retinoid
  • Topical Retinoid

By Country:

  • The United States
  • Canada
  • Rest of North America

Based on geography, North America holds a considerable share in the global acne medication market. It is expected to grow at a reasonable rate due to rising acne disorders among the people. According to the American Academy of Dermatology, Acne is the most common skin disease among the public, with 50 million Americans getting infected annually. The North American market is highly fragmented. Companies use various strategies like new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. Companies are now using celebrities for their promotion as many people follow them and are ready to buy products just by seeing them using the product.

Some of the major companies dominating the North America Acne medication market by their products and services include Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co. Inc., Amgen, Inc., Abbott Laboratories, AstraZeneca, Eli Lilly and Company, Mylan N.V., and Daiichi Sankyo Company, Ltd.

1.Introduction                                                                                  

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

2. Research Methodology                                                                                           

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

3. Overview                                                                                       

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 Epidemology                                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

5. Market Segmentation                                                                                              

                5.1 Type                                                                              

                                5.1.1 Introduction                                                           

                                5.1.2 OTC drugs                                                

                                5.1.3 Prescription drugs                                                

                                5.1.4  Y-o-Y Growth Analysis, By type                                                     

                                5.1.5  Market Attractiveness Analysis, By type                                                   

                                5.1.6 Market Share Analysis, By type                                                      

                5.2 Route of administration                                                                        

                                5.2.1 Introduction                                                           

                                5.2.2 Topical                                                      

                                5.2.3 Oral                                                            

                                5.2.4 Y-o-Y Growth Analysis, By route of administration                                                

                                5.2.5 Market Attractiveness Analysis, By route of administration                                                              

                                5.2.6 Market Share Analysis, By route of administration                                                

                5.3 Drug class                                                                    

                                5.3.1 Introduction                                                           

                                5.3.2 Antibiotics                                                               

                                5.3.3 Anti-inflammatory drugs                                                   

                                5.3.4 Anti-microbials                                                      

                                5.3.5 Combination drugs                                                              

                                5.3.6 Hormonal agents                                                  

                                5.3.7 Oral retinoids                                                         

                                5.3.8 Topical retinoids                                                   

                                5.3.7 Y-o-Y Growth Analysis, By drug class                                                            

                                5.3.8  Market Attractiveness Analysis, By drug class                                                         

                                5.3.9  Market Share Analysis, By drug class                                                          

6. Geographical Analysis                                                                                              

                6.1 Introduction                                                                               

                                6.1.1 Regional Trends                                                    

                                6.1.2 Impact Analysis                                                     

                                6.1.3 Y-o-Y Growth Analysis                                                        

                                                6.1.3.1 By Geographical Area                                     

                                                6.1.3.2 By type                                 

                                                6.1.3.3 By route of administration                                            

                                                6.1.3.4 By drug class                                       

                                6.1.4  Market Attractiveness Analysis                                                     

                                                6.1.4.1 By Geographical Area                                     

                                                6.1.4.2 By type                                 

                                                6.1.4.3 By route of administration                                            

                                                6.1.4.4 By drug class                                       

                                6.1.5  Market Share Analysis                                                      

                                                6.1.5.1 By Geographical Area                                     

                                                6.1.5.2 By type                                 

                                                6.1.5.3 By route of administration                                            

                                                6.1.5.4 By drug class                                       

                6.2 United States                                                                            

                6.3 Canada                                                                         

7. Strategic Analysis                                                                                       

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis                                                                                        

                8.1 Pfizer Inc.                                                                    

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Financial analysis                                                  

                                8.1.4 Recent Developments                                                       

                                8.1.5 SWOT analysis                                                       

                                8.1.6 Analyst View                                                          

                8.2 GlaxoSmithKline plc                                                                

                8.3 Novartis AG                                                                

                8.4 Merck & Co. Inc                                                                        

                8.5 Amgen, Inc.                                                                

                8.6 Abbott Laboratories                                                                               

                8.7 Eli Lilly and Company                                                                              

                8.8 Daiichi Sankyo Company, Ltd                                                                              

9. Competitive Landscape                                                                                           

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

10. Market Outlook and Investment Opportunities                                                                                         

Appendix                                                                                           

                a) List of Tables                                                                

                b) List of Figures                                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of route, by Type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

  1. North America Acne Medication Market, By Type, From 2021 to 2026 (USD Billion)
  2. North America Otc drugs Market, By Region, From 2021 to 2026 (USD Billion)
  3. North America Prescription drugs Market, By Region, From 2021 to 2026 (USD Billion)
  4. North America Acne Medication Market, By Route of administration, From 2021 to 2026 (USD Billion)
  5. North America Topical Market, By Region, From 2021 to 2026 (USD Billion)
  6. North America Oral Market, By Region, From 2021 to 2026 (USD Billion)
  7. North America Acne Medication Market, By Drug class, From 2021 to 2026 (USD Billion)
  8. North America Antibiotics Market, By Region, From 2021 to 2026 (USD Billion)
  9. North America Anti-inflammatory  Market, By Region, From 2021 to 2026 (USD Billion)
  10. North America Antimicrobials Market, By Region, From 2021 to 2026 (USD Billion)
  11. North America Combination Market, By Region, From 2021 to 2026 (USD Billion)
  12. North America Hormonla agents Market, By Region, From 2021 to 2026 (USD Billion)
  13. North America Oral retinoids Market, By Region, From 2021 to 2026 (USD Billion)
  14. North America Topical retinoids Market, By Region, From 2021 to 2026 (USD Billion)
  15. United States Acne Medication Market, By Type, From 2021 to 2026 (USD Billion)
  16. United States Acne Medication Market, By Route of administration, From 2021 to 2026 (USD Billion)
  17. United States Acne Medication Market, By Drug class, From 2021 to 2026 (USD Billion)
  18. Canada Acne Medication Market, By Type, From 2021 to 2026 (USD Billion)
  19. Canada Acne Medication Market, By Route of administration, From 2021 to 2026 (USD Billion)
  20. Canada Acne Medication Market, By Drug class, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample